Home/Filings/4/0001127602-22-025655
4//SEC Filing

PENDARVIS DAVID 4

Accession 0001127602-22-025655

CIK 0000943819other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 6:26 PM ET

Size

7.6 KB

Accession

0001127602-22-025655

Insider Transaction Report

Form 4
Period: 2022-11-11
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
  • Tax Payment

    ResMed Common Stock

    2022-11-11$225.18/sh450$101,331101,927 total
  • Tax Payment

    ResMed Common Stock

    2022-11-11$225.18/sh279$62,825101,311 total
  • Tax Payment

    ResMed Common Stock

    2022-11-11$225.18/sh337$75,886101,590 total
Footnotes (3)
  • [F1]Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.
  • [F2]Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2020.
  • [F3]Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001196723

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:26 PM ET
Size
7.6 KB